Tenaya Therapeutics, Inc. (TNYA) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $21K. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 10, 2026 | Ali Faraz Chief Executive Officer | $0 | 854,500 | +20% | No | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 10, 2026 | Tingley Whittemore Chief Medical Officer | $0 | 342,000 | +20% | No | |
|
|
||||||
| Aug. 17, 2026 | Ali Faraz Chief Executive Officer | −$15,778 | 22,232 | −5% | No | |
|
|
||||||
| Aug. 17, 2026 | Tingley Whittemore Chief Medical Officer | −$5,270 | 7,424 | −3% | No | |
|
|
||||||
| July 14, 2026 filed July 13, 2026 | Hyllengren Eric J Chief Financial Officer | $0 | 1,650,000 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free